UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

COVID-19: progression of disease and intravascular coagulation - present status and future perspectives

Clinical chemistry and laboratory medicine, 2020-07, Vol.58 (7), p.1029-1036

2020

Volltextzugriff (PDF)

Development of idraparinux and idrabiotaparinux for anticoagulant therapy

Thrombosis and haemostasis, 2009-11, Vol.102 (5), p.811-815

Harenberg, Job

2009

Volltextzugriff (PDF)

Acquired Autoimmune Hemophilia Following SARS-CoV-2 Vaccines: Dual-Drug Effects on Blood Coagulation and the Scylla and Charybdis Phenomenon

Thrombosis and haemostasis, 2021-12, Vol.121 (12), p.1555-1557

2021

Volltextzugriff (PDF)

Patients’ Plasma Activity of Heparin, low-Molecular-Weight Heparin or no Anticoagulants on Urine Based DOAC Test Strips

Clinical and applied thrombosis/hemostasis, 2022-03, Vol.28, p.10760296221083667-10760296221083667

2022

Volltextzugriff (PDF)

Performance Characteristics of DOAC Dipstick in Determining Direct Oral Anticoagulants in Urine

Clinical and applied thrombosis/hemostasis, 2021, Vol.27, p.1076029621993550-1076029621993550

2021

Volltextzugriff (PDF)

Comparison of the DOAC Dipstick Test on Urine Samples With Chromogenic Substrate Methods on Plasma Samples in Outpatients Treated With Direct Oral Anticoagulants

Clinical and applied thrombosis/hemostasis, 2023-01, Vol.29, p.10760296231179684-10760296231179684

2023

Volltextzugriff (PDF)

Discovery of PG545: A Highly Potent and Simultaneous Inhibitor of Angiogenesis, Tumor Growth, and Metastasis

Journal of medicinal chemistry, 2012-04, Vol.55 (8), p.3804-3813

2012

Volltextzugriff (PDF)

Differences of Present Recommendations and Guidelines for Generic Low-Molecular-Weight Heparins: Is There Room for Harmonization

Clinical and Applied Thrombosis/Hemostasis, 2011-11, Vol.17 (6), p.E158-E164

Harenberg, Job

2011

Volltextzugriff (PDF)

Determination of rivaroxaban in human plasma samples

Seminars in thrombosis and hemostasis, 2012-03, Vol.38 (2), p.178-184

2012

Volltextzugriff (PDF)

Anticoagulant Treatment of COVID-19 as Early as Possible—Sulodexide and Perspectives

Thrombosis and haemostasis, 2021-07, Vol.121 (7), p.849-853

2021

Volltextzugriff (PDF)

Waves of SARS-CoV-2 Infection and Blood Coagulation-A Link and Beyond

Thrombosis and haemostasis, 2021-01, Vol.121 (1), p.4-6

2021

Volltextzugriff (PDF)

Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability

Journal of thrombosis and thrombolysis, 2011-10, Vol.32 (3), p.267-271

2011

Volltextzugriff (PDF)

Past, present, and future perspectives of heparins in clinical settings and the role of impaired renal function

International journal of cardiology, 2016-06, Vol.212, p.S10-S13

Harenberg, Job

2016

Volltextzugriff (PDF)

The Dangerous Liaisons between Chronic Obstructive Pulmonary Disease and Venous Thromboembolism

Thrombosis and haemostasis, 2020-03, Vol.120 (3), p.363-365

2020

Volltextzugriff (PDF)

Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysis

Internal and emergency medicine, 2017-12, Vol.12 (8), p.1291-1305

2017

Volltextzugriff (PDF)

Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany

BioMed research international, 2015-01, Vol.2015 (2015), p.1-12

2015

Volltextzugriff (PDF)

Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women

Thrombosis and haemostasis, 2007-12, Vol.98 (6), p.1237-1245

2007

Volltextzugriff (PDF)

Laboratory determination of old and new targeted anticoagulant agents for prevention of bleeding and thrombotic events in cancer patients

Thrombosis research, 2016-04, Vol.140, p.S165-S167

Harenberg, Job

2016

Volltextzugriff (PDF)

Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine

Thrombosis and haemostasis, 2020-12, Vol.120 (12), p.1597-1628

2020

Volltextzugriff (PDF)

Detection and neutralisation of heparin by a fluorescent ruthenium compound

Thrombosis and haemostasis, 2009-11, Vol.102 (5), p.859-864

2009

Volltextzugriff (PDF)

Synthesis and Biological Evaluation of Polysulfated Oligosaccharide Glycosides as Inhibitors of Angiogenesis and Tumor Growth

Journal of medicinal chemistry, 2010-02, Vol.53 (4), p.1686-1699

2010

Volltextzugriff (PDF)

Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs – A Systematic Review and Meta-analysis

TH open : companion journal to thrombosis and haemostasis, 2021-07, Vol.5 (3), p.e438-e448

2021

Volltextzugriff (PDF)

Heparin and its derivatives - present and future

Thrombosis and haemostasis, 2009-11, Vol.102 (5), p.801-802

2009

Volltextzugriff (PDF)

New developments in anticoagulants: Past, present and future

Thrombosis and haemostasis, 2017, Vol.117 (7), p.1283-1288

2017

Volltextzugriff (PDF)

Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)?

Seminars in thrombosis and hemostasis, 2021-06, Vol.47 (4), p.338-340

2021

Volltextzugriff (PDF)

1 – 25 von 232

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(157)

Publikationsform

Sprache

Englisch
(221)
Deutsch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(153)
Life Sciences & Biomedicine
(151)
Humans
(120)
Hematology
(112)
Cardiovascular System & Cardiology
(101)
Peripheral Vascular Disease
(98)
Biological And Medical Sciences
(62)
Medical Sciences
(59)
Pharmacology. Drug Treatments
(39)
Female
(37)
Anticoagulants - Administration & Dosage
(36)
Male
(34)
Heparin
(31)
Anticoagulants - Therapeutic Use
(30)
Blood. Blood Coagulation. Reticuloendothelial System
(29)
Aged
(27)
Middle Aged
(27)
Anticoagulants - Adverse Effects
(26)
Adult
(25)
Anticoagulants
(24)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

COVID-19: progression of disease and intravascular coagulation - present status and future perspectives

Development of idraparinux and idrabiotaparinux for anticoagulant therapy

Acquired Autoimmune Hemophilia Following SARS-CoV-2 Vaccines: Dual-Drug Effects on Blood Coagulation and the Scylla and Charybdis Phenomenon

Patients’ Plasma Activity of Heparin, low-Molecular-Weight Heparin or no Anticoagulants on Urine Based DOAC Test Strips

Performance Characteristics of DOAC Dipstick in Determining Direct Oral Anticoagulants in Urine

Comparison of the DOAC Dipstick Test on Urine Samples With Chromogenic Substrate Methods on Plasma Samples in Outpatients Treated With Direct Oral Anticoagulants

Discovery of PG545: A Highly Potent and Simultaneous Inhibitor of Angiogenesis, Tumor Growth, and Metastasis

Differences of Present Recommendations and Guidelines for Generic Low-Molecular-Weight Heparins: Is There Room for Harmonization

Determination of rivaroxaban in human plasma samples

Anticoagulant Treatment of COVID-19 as Early as Possible—Sulodexide and Perspectives

Waves of SARS-CoV-2 Infection and Blood Coagulation-A Link and Beyond

Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability

Past, present, and future perspectives of heparins in clinical settings and the role of impaired renal function

The Dangerous Liaisons between Chronic Obstructive Pulmonary Disease and Venous Thromboembolism

Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysis

Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany

Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women

Laboratory determination of old and new targeted anticoagulant agents for prevention of bleeding and thrombotic events in cancer patients

Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine

Detection and neutralisation of heparin by a fluorescent ruthenium compound

Synthesis and Biological Evaluation of Polysulfated Oligosaccharide Glycosides as Inhibitors of Angiogenesis and Tumor Growth

Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs – A Systematic Review and Meta-analysis

Heparin and its derivatives - present and future

New developments in anticoagulants: Past, present and future

Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)?

Suchergebnisse filtern